Showing results (31-40 of 98) with videos related to
Sort By:
Pageof 10
Transgenic Research|November 27, 2012
Transgenic sheep generated by lentiviral vectors: safety and integration analysis of surrogates and their offspringKenneth Cornetta, Kimberly Tessanne, Charles Long, et al.Experimental Hematology|March 30, 2006
Decreased homing of retrovirally transduced human bone marrow CD34+ cells in the NOD/SCID mouse modelKristin M Hall, Tamara L Horvath, Rafat Abonour, et al.Journal of Pain and Symptom Management|August 1, 2021
Palliative Care Needs in Breast Cancer Patients Entering Inpatient Hospice in Western KenyaAllison Tarus, Kenneth Cornetta, Daniel Morogo, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 12, 2006
G2 cell cycle arrest and cyclophilin A in lentiviral gene transferShangming Zhang, Guiandre Joseph, Karen Pollok, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 6, 2003
Certification assays for HIV-1-based vectors: frequent passage of gag sequences without evidence of replication-competent virusesLakshmi Sastry, Yi Xu, Terry Johnson, et al.Clinical and Translational Science|August 8, 2013
Partnership between CTSI and business schools can promote best practices for core facilities and resourcesLilith Reeves, Linda M Dunn-Jensen, Timothy T Baldwin, et al.Bioinformatics (Oxford, England)|January 20, 2011
Identifying viral integration sites using SeqMap 2.0Troy B Hawkins, Jessica Dantzer, Brandon Peters, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 30, 2006
Desensitization to imatinib in patients with leukemiaRobert P Nelson, Kenneth Cornetta, Kelly E Ward, et al.Biomedicines|May 27, 2017
Development and Evaluation of Quality Metrics for Bioinformatics Analysis of Viral Insertion Site Data Generated Using High Throughput SequencingHongyu Gao, Troy Hawkins, Aparna Jasti, et al.Leukemia & Lymphoma|October 1, 2005
Augmented high-dose regimen of cyclophosphamide, carmustine, and etoposide with autologous hematopoietic stem cell transplantation for relapsed and refractory aggressive non-Hodgkin's lymphomaMichael J Robertson, Rafat Abonour, Robert Hromas, et al.Pageof 10